ストックスクリーナーアプリを入手
10.24
2.85%
-0.30
前日終値:
$10.54
開ける：
$10.49
24時間の取引高:
232.04K
Relative Volume:
0.94
時価総額：
$380.21M
収益：
-
当期純損益:
$-63.78M
株価収益率:
-3.8209
EPS:
-2.68
ネットキャッシュフロー:
$-53.91M
1週間 パフォーマンス:
-2.48%
1か月 パフォーマンス:
+7.79%
6か月 パフォーマンス:
-28.89%
1年 パフォーマンス:
-52.59%
1日の値動き範囲:
$10.06
$10.67
1週間の範囲:
$9.9763
$11.17
52週間の値動き範囲:
$8.75
$22.04
Celcuity Inc Stock (CELC) Company Profile
CELC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
10.24 | 380.21M | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-02-22 | 開始されました | Stifel | Buy |
| 2023-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-09-07 | 開始されました | Jefferies | Buy |
| 2021-07-29 | 開始されました | Cowen | Outperform |
| 2021-07-27 | 開始されました | Needham | Buy |
| 2021-01-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-11 | 再開されました | Craig Hallum | Buy |
| 2018-11-20 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Celcuity Inc (CELC) 最新ニュース
Charles Schwab Investment Management Inc. Has $3.11 Million Stock Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Bank of New York Mellon Corp Buys 10,828 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity (CELC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Celcuity at Leerink Global Healthcare Conference: Promising Cancer Drug Insights By Investing.com - Investing.com South Africa
Celcuity at Leerink Global Healthcare Conference: Promising Cancer Drug Insights - Investing.com Canada
BlackRock, Inc. Expands Holdings with Celcuity Inc. Acquisition - GuruFocus.com
Rhumbline Advisers Boosts Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
(CELC) Technical Data - Stock Traders Daily
Brokerages Set Celcuity Inc. (NASDAQ:CELC) Target Price at $30.17 - Defense World
Celcuity, Inc. to Host Earnings Call - ACCESS Newswire
New York State Common Retirement Fund Purchases 3,682 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 - Quantisnow
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity stock touches 52-week low at $10.35 amid market challenges - Investing.com India
Celcuity stock touches 52-week low at $10.35 amid market challenges By Investing.com - Investing.com South Africa
Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences - The Manila Times
Celcuity Inc. (NASDAQ:CELC) Short Interest Up 6.4% in January - MarketBeat
Celcuity Set to Join Russell 2000 and 3000 Indexes - ACCESS Newswire
Celcuity’s High-Stakes Oncology Bet Is Underappreciated (NASDAQ:CELC) - Seeking Alpha
Q1 Earnings Forecast for Celcuity Issued By Leerink Partnrs - MarketBeat
Bleakley Financial Group LLC Acquires Shares of 11,159 Celcuity Inc. (NASDAQ:CELC) - Defense World
Q2 Earnings Estimate for Celcuity Issued By Leerink Partnrs - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat
Needham & Company LLC Issues Positive Forecast for Celcuity (NASDAQ:CELC) Stock Price - MarketBeat
Q1 Earnings Estimate for Celcuity Issued By Leerink Partnrs - Defense World
Celcuity Inc. (NASDAQ:CELC) Receives $30.17 Consensus Price Target from Brokerages - Defense World
Scorpion stinger bringer of more PI3Kα inhibitor deals? - BioWorld Online
JPMorgan Chase & Co. Sells 11,612 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity to Participate in the Canaccord Genuity 41st Annual Growth Conference - ACCESS Newswire
Celcuity Inc. Reports Fourth Quarter and Full Year 2021 Financial Results, Pivotal Phase 3 Trial Design for Gedatolisib in the Treatment of Advanced Breast Cancer, and Business Updates - ACCESS Newswire
Celcuity Announces FDA Breakthrough Therapy Designation for Gedatolisib for Treatment of HR+/HER2- Metastatic Breast Cancer - ACCESS Newswire
When (CELC) Moves Investors should Listen - Stock Traders Daily
Jefferies lifts Celcuity stock target to $33, maintains Buy rating - MSN
Jefferies lifts Celcuity stock target to $33, maintains Buy rating By Investing.com - Investing.com Australia
Celcuity Closes $100 Million Private Placement - ACCESS Newswire
Celcuity Inc. Announces $50 Million Private Placement - ACCESS Newswire
Hennion & Walsh Asset Management Inc. Buys 71,006 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc (CELC) 財務データ
収益
当期純利益
現金流量
EPS
Celcuity Inc (CELC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Buller Richard E | Director |
Oct 23 '24 |
Sale |
16.25 |
350 |
5,688 |
6,681 |
| Buller Richard E | Director |
Aug 23 '24 |
Sale |
16.95 |
350 |
5,932 |
7,031 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):